Cargando…

Alterations of the gut microbiota and short chain fatty acids in necrotizing enterocolitis and food protein-induced allergic protocolitis infants: A prospective cohort study

BACKGROUND: Even though presenting with similar clinical manifestations, necrotizing enterocolitis (NEC) and food protein-induced allergic protocolitis (FPIAP) have completely different treatments and prognosis. Our study aimed to quantify and evaluate differences in gut microbiota and short chain f...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiong, Jing, Liao, Xing-Sheng, Yin, Tong, Liu, Xiao-Chen, Bao, Lei, Li, Lu-Quan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9720398/
https://www.ncbi.nlm.nih.gov/pubmed/36478672
http://dx.doi.org/10.3389/fcimb.2022.1030588
_version_ 1784843548994043904
author Xiong, Jing
Liao, Xing-Sheng
Yin, Tong
Liu, Xiao-Chen
Bao, Lei
Li, Lu-Quan
author_facet Xiong, Jing
Liao, Xing-Sheng
Yin, Tong
Liu, Xiao-Chen
Bao, Lei
Li, Lu-Quan
author_sort Xiong, Jing
collection PubMed
description BACKGROUND: Even though presenting with similar clinical manifestations, necrotizing enterocolitis (NEC) and food protein-induced allergic protocolitis (FPIAP) have completely different treatments and prognosis. Our study aimed to quantify and evaluate differences in gut microbiota and short chain fatty acids (SCFAs) between infants with NEC and FPIAP to better identify these two diseases in clinical settings. METHODS: A total of 43 infants with NEC or FPIAP in Children’s Hospital of Chongqing Medical University, China between December 2020 and December 2021 were enrolled. Stool samples were prospectively collected and froze. Infants defined as NEC were those who presented with clinical courses consistent with NEC and whose radiographs fulfilled criteria for Bell’s stage 2 or 3 NEC, while those who were healthy in appearance and had blood in the stool (visible or may be microscopic), had normal bowel sounds in physical examination, were resolved after eliminating the causative food, and/or had recurrence of symptoms after oral food challenge (OFC) were defined as FPIAP. Primers specific for bacterial 16S rRNA genes were used to amplify and pyrosequence fecal DNA from stool samples. Gas chromatography-mass spectrometry (GC-MS) technology was used to determine the concentrations of SCFAs. RESULTS: Among the 43 infants, 22 were diagnosed with NEC and 21 were diagnosed with FPIAP. The microbial community structure in NEC infant stools differed significantly from those in FPIAP infant stools. NEC infants had significantly higher proportion of Actinobacteria and reduced proportion of Bacteroidetes compared with FPIAP infants, and the proportions of Halomonas, Acinetobacter, Bifidobacterium, and Stenotrophomonas in NEC infants were significantly higher than that of FPIAP infants. In addition, infants with NEC had significantly lower levels of acetic acid, propionic acid, butyric acid, isovaleric acid, and total SCFAs, and higher level of hexanoic acid as compared to the infants of the FPIAP group. CONCLUSIONS: The differences of gut microbiota composition and concentrations of SCFAs might represent suitable biomarker targets for early identification of NEC and FPIAP.
format Online
Article
Text
id pubmed-9720398
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-97203982022-12-06 Alterations of the gut microbiota and short chain fatty acids in necrotizing enterocolitis and food protein-induced allergic protocolitis infants: A prospective cohort study Xiong, Jing Liao, Xing-Sheng Yin, Tong Liu, Xiao-Chen Bao, Lei Li, Lu-Quan Front Cell Infect Microbiol Cellular and Infection Microbiology BACKGROUND: Even though presenting with similar clinical manifestations, necrotizing enterocolitis (NEC) and food protein-induced allergic protocolitis (FPIAP) have completely different treatments and prognosis. Our study aimed to quantify and evaluate differences in gut microbiota and short chain fatty acids (SCFAs) between infants with NEC and FPIAP to better identify these two diseases in clinical settings. METHODS: A total of 43 infants with NEC or FPIAP in Children’s Hospital of Chongqing Medical University, China between December 2020 and December 2021 were enrolled. Stool samples were prospectively collected and froze. Infants defined as NEC were those who presented with clinical courses consistent with NEC and whose radiographs fulfilled criteria for Bell’s stage 2 or 3 NEC, while those who were healthy in appearance and had blood in the stool (visible or may be microscopic), had normal bowel sounds in physical examination, were resolved after eliminating the causative food, and/or had recurrence of symptoms after oral food challenge (OFC) were defined as FPIAP. Primers specific for bacterial 16S rRNA genes were used to amplify and pyrosequence fecal DNA from stool samples. Gas chromatography-mass spectrometry (GC-MS) technology was used to determine the concentrations of SCFAs. RESULTS: Among the 43 infants, 22 were diagnosed with NEC and 21 were diagnosed with FPIAP. The microbial community structure in NEC infant stools differed significantly from those in FPIAP infant stools. NEC infants had significantly higher proportion of Actinobacteria and reduced proportion of Bacteroidetes compared with FPIAP infants, and the proportions of Halomonas, Acinetobacter, Bifidobacterium, and Stenotrophomonas in NEC infants were significantly higher than that of FPIAP infants. In addition, infants with NEC had significantly lower levels of acetic acid, propionic acid, butyric acid, isovaleric acid, and total SCFAs, and higher level of hexanoic acid as compared to the infants of the FPIAP group. CONCLUSIONS: The differences of gut microbiota composition and concentrations of SCFAs might represent suitable biomarker targets for early identification of NEC and FPIAP. Frontiers Media S.A. 2022-11-21 /pmc/articles/PMC9720398/ /pubmed/36478672 http://dx.doi.org/10.3389/fcimb.2022.1030588 Text en Copyright © 2022 Xiong, Liao, Yin, Liu, Bao and Li https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cellular and Infection Microbiology
Xiong, Jing
Liao, Xing-Sheng
Yin, Tong
Liu, Xiao-Chen
Bao, Lei
Li, Lu-Quan
Alterations of the gut microbiota and short chain fatty acids in necrotizing enterocolitis and food protein-induced allergic protocolitis infants: A prospective cohort study
title Alterations of the gut microbiota and short chain fatty acids in necrotizing enterocolitis and food protein-induced allergic protocolitis infants: A prospective cohort study
title_full Alterations of the gut microbiota and short chain fatty acids in necrotizing enterocolitis and food protein-induced allergic protocolitis infants: A prospective cohort study
title_fullStr Alterations of the gut microbiota and short chain fatty acids in necrotizing enterocolitis and food protein-induced allergic protocolitis infants: A prospective cohort study
title_full_unstemmed Alterations of the gut microbiota and short chain fatty acids in necrotizing enterocolitis and food protein-induced allergic protocolitis infants: A prospective cohort study
title_short Alterations of the gut microbiota and short chain fatty acids in necrotizing enterocolitis and food protein-induced allergic protocolitis infants: A prospective cohort study
title_sort alterations of the gut microbiota and short chain fatty acids in necrotizing enterocolitis and food protein-induced allergic protocolitis infants: a prospective cohort study
topic Cellular and Infection Microbiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9720398/
https://www.ncbi.nlm.nih.gov/pubmed/36478672
http://dx.doi.org/10.3389/fcimb.2022.1030588
work_keys_str_mv AT xiongjing alterationsofthegutmicrobiotaandshortchainfattyacidsinnecrotizingenterocolitisandfoodproteininducedallergicprotocolitisinfantsaprospectivecohortstudy
AT liaoxingsheng alterationsofthegutmicrobiotaandshortchainfattyacidsinnecrotizingenterocolitisandfoodproteininducedallergicprotocolitisinfantsaprospectivecohortstudy
AT yintong alterationsofthegutmicrobiotaandshortchainfattyacidsinnecrotizingenterocolitisandfoodproteininducedallergicprotocolitisinfantsaprospectivecohortstudy
AT liuxiaochen alterationsofthegutmicrobiotaandshortchainfattyacidsinnecrotizingenterocolitisandfoodproteininducedallergicprotocolitisinfantsaprospectivecohortstudy
AT baolei alterationsofthegutmicrobiotaandshortchainfattyacidsinnecrotizingenterocolitisandfoodproteininducedallergicprotocolitisinfantsaprospectivecohortstudy
AT liluquan alterationsofthegutmicrobiotaandshortchainfattyacidsinnecrotizingenterocolitisandfoodproteininducedallergicprotocolitisinfantsaprospectivecohortstudy